P-0042 Preliminary Safety Analysis From PAC-C Study of Capecitabine+Paclitaxel→Capecitabine Maintenance (PX-X) vs Capecitabine+Cisplatin (XP) As First-Line Chemotherapy for Recurrent/Metastatic Gastric Cancer

Annals of Oncology - Tập 23 - Trang iv43-iv44 - 2012
Lin Shen1, Xiaotian Zhang1, Zhihao Lu1, Bing Hu2, Qingxia Fan3, Wei Li4, Wei Liu5, Tianshu Liu6, Yueyin Pan7, Nong Xu8
1Department of Gastrointestinal Oncology, Key laboratory of Carcinogenesis & Translational Research under Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing
2Anhui provincial hospital, Anhui, China
3The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
4First Bethune Hospital of Jilin University, Changchun, China
5Hebei Medical University Fourth Hospital, Shijiazhuang, Hebei
6Zhongshan Hospital of Fudan University, Shanghai, China
7The First Affiliated Hospital of Anhui Medical University, Hefei, China
8The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China